download laufapp   -   runletter anmelden   -   on twitter   -   tracklist   -   running stocks   -   runplugged baa   -   runkit   -   charity

Semperit AG Holding / Group interim report for 3rd quarter shows significant EBITDA improvement – EBIT and earnings after tax are negative after one-off effects in Medical Sector


Markus Keller ist seit April 2017 Leiter des Segments Sempertrans; Bild: Semperit
>> Öffnen auf photaq.com
Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
Quarterly Report
Vienna -
Group revenue decreased by 2.7% to EUR 652.2 million\nEBITDA increased to EUR 60.4 million (after one-off effect), EBITDA margin to 9.3%\nImpairment loss in Medical Sector: EUR 46.8 million\nGroup EBIT after impairment loss in Medical Sector at EUR -13.7 million, EBIT margin at -2.1%\nAdjusted EBIT at EUR 29.0 million, adjusted EBIT margin at 4.4%\nEarnings after tax: EUR -34.1 million, adjusted EUR 8.6 million\nVienna/Austria, 19 December 2019 - The publicly listed Semperit Group significantly improved the operating results with increasing profitability on EBITDA level in the first three quarters of 2019, while revenue declined slightly. In the first three quarters of 2019, total revenue recorded a year-on- year decline of 2.7% to EUR 652.2 million.
EBITDA rose from EUR 41.9 million in the first three quarters of 2018 to EUR 60.4 million in the first three quarters of 2019. Adjusted for the one-off effects, EBITDA rose from EUR 45.8 million in the past year(1) to EUR 56.4 million until the third quarter of 2019(2). The EBITDA margin rose from 6.3% to 9.3% in the first three quarters of 2019 and reflects the profitability improved by the restructuring and transformation process (adjusted: 8.6% versus 6.8% in the previous year). As a result, the aggregated value for 2018 was already exceeded at the end of the third quarter.
Due to current information on the competitive situation of the medical business, an impairment loss of EUR 46.8 million was recognized in the Medical Sector. The background to this is the investment intensity of the significant competitors, which increased beyond expectations through capacity expansion and production automation, and the highly dynamic development of the market environment. Despite Sempermed segment's progress regarding the improvement of operating results, which is quicker than planned, it is to be expected that overcapacities on the market and the resulting price pressure will affect the profitability in a significantly negative manner.
Group EBIT improved to EUR -13.7 million in the first three quarters of 2019 from EUR -45.5 million in the previous year. EBITDA margin was -2.1% after - 6.8%. Adjusted for one-off effects(3), EBIT amounted to EUR 29.0 million compared to EUR 17.5 million in the previous year. The adjusted EBIT margin improved to 4.4.% versus 2.6% in the comparable period in the previous year.
Earnings after tax improved in the first three quarters of 2019 to EUR -34.1 million compared to EUR -72.9 million for the first three quarters of 2018. Earnings per share amounted to EUR -1.66 compared with -3.68 in the same period of 2018. Adjusted for one-off effects, the earnings after tax amounted to EUR 8.6 million compared with EUR -9.9 million in the same period of the previous year.
1) Excluding the negative one-off effect of EUR 3.9 million from the closure of the Sempertrans site in China for the first three quarters of 2018 2) Excluding the positive one-off effect of EUR 4.0 million from the reversal of a provision for the tax proceedings on levies in Brazil 3) Q1-3 2019: reversal of a provision of EUR 4.0 million and impairment loss at Sempermed of EUR 46.8 million; Q1-3 2018: EUR 3.9 million from the closure of the Sempertrans site in China and impairment loss especially at Sempermed of EUR 55.2 million
end of announcement euro adhoc
issuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wien phone: +43 1 79 777-310 FAX: +43 1 79 777-602 mail: judit.helenyi@semperitgroup.com WWW: www.semperitgroup.com ISIN: AT0000785555 indexes: WBI, ATX PRIME, ATX GP stockmarkets: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/2918/aom
Random Partner

KTM
Unser Hauptpartner beim Business Athlete Award, http://www.runplugged.com/baa . Die KTM Industries-Gruppe ist eine europäische Fahrzeug-Gruppe mit dem strategischen Fokus auf das globale Sportmotorradsegment und den automotiven high-tech Komponentenbereich. Mit ihren weltweit bekannten Marken KTM, Husqvarna Motorcycles, WP und Pankl zählt sie in ihren Segmenten jeweils zu den Technologie- und Marktführern.

>> Besuchen Sie 2 weitere Partner auf runplugged.com/partner





Runplugged App

runplugged.com/app


Weitere Aktivitäten

Facebook https://www.facebook.com/runplugged.social.laufapp
Runplugged Business Athlete Award: http://runplugged.com/baa

Semperit AG Holding / Group interim report for 3rd quarter shows significant EBITDA improvement – EBIT and earnings after tax are negative after one-off effects in Medical Sector


Markus Keller ist seit April 2017 Leiter des Segments Sempertrans; Bild: Semperit
>> Öffnen auf photaq.com
Corporate news transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.
Quarterly Report
Vienna -
Group revenue decreased by 2.7% to EUR 652.2 million\nEBITDA increased to EUR 60.4 million (after one-off effect), EBITDA margin to 9.3%\nImpairment loss in Medical Sector: EUR 46.8 million\nGroup EBIT after impairment loss in Medical Sector at EUR -13.7 million, EBIT margin at -2.1%\nAdjusted EBIT at EUR 29.0 million, adjusted EBIT margin at 4.4%\nEarnings after tax: EUR -34.1 million, adjusted EUR 8.6 million\nVienna/Austria, 19 December 2019 - The publicly listed Semperit Group significantly improved the operating results with increasing profitability on EBITDA level in the first three quarters of 2019, while revenue declined slightly. In the first three quarters of 2019, total revenue recorded a year-on- year decline of 2.7% to EUR 652.2 million.
EBITDA rose from EUR 41.9 million in the first three quarters of 2018 to EUR 60.4 million in the first three quarters of 2019. Adjusted for the one-off effects, EBITDA rose from EUR 45.8 million in the past year(1) to EUR 56.4 million until the third quarter of 2019(2). The EBITDA margin rose from 6.3% to 9.3% in the first three quarters of 2019 and reflects the profitability improved by the restructuring and transformation process (adjusted: 8.6% versus 6.8% in the previous year). As a result, the aggregated value for 2018 was already exceeded at the end of the third quarter.
Due to current information on the competitive situation of the medical business, an impairment loss of EUR 46.8 million was recognized in the Medical Sector. The background to this is the investment intensity of the significant competitors, which increased beyond expectations through capacity expansion and production automation, and the highly dynamic development of the market environment. Despite Sempermed segment's progress regarding the improvement of operating results, which is quicker than planned, it is to be expected that overcapacities on the market and the resulting price pressure will affect the profitability in a significantly negative manner.
Group EBIT improved to EUR -13.7 million in the first three quarters of 2019 from EUR -45.5 million in the previous year. EBITDA margin was -2.1% after - 6.8%. Adjusted for one-off effects(3), EBIT amounted to EUR 29.0 million compared to EUR 17.5 million in the previous year. The adjusted EBIT margin improved to 4.4.% versus 2.6% in the comparable period in the previous year.
Earnings after tax improved in the first three quarters of 2019 to EUR -34.1 million compared to EUR -72.9 million for the first three quarters of 2018. Earnings per share amounted to EUR -1.66 compared with -3.68 in the same period of 2018. Adjusted for one-off effects, the earnings after tax amounted to EUR 8.6 million compared with EUR -9.9 million in the same period of the previous year.
1) Excluding the negative one-off effect of EUR 3.9 million from the closure of the Sempertrans site in China for the first three quarters of 2018 2) Excluding the positive one-off effect of EUR 4.0 million from the reversal of a provision for the tax proceedings on levies in Brazil 3) Q1-3 2019: reversal of a provision of EUR 4.0 million and impairment loss at Sempermed of EUR 46.8 million; Q1-3 2018: EUR 3.9 million from the closure of the Sempertrans site in China and impairment loss especially at Sempermed of EUR 55.2 million
end of announcement euro adhoc
issuer: Semperit AG Holding Modecenterstrasse 22 A-1030 Wien phone: +43 1 79 777-310 FAX: +43 1 79 777-602 mail: judit.helenyi@semperitgroup.com WWW: www.semperitgroup.com ISIN: AT0000785555 indexes: WBI, ATX PRIME, ATX GP stockmarkets: Wien language: English
Digital press kit: http://www.ots.at/pressemappe/2918/aom
Random Partner

KTM
Unser Hauptpartner beim Business Athlete Award, http://www.runplugged.com/baa . Die KTM Industries-Gruppe ist eine europäische Fahrzeug-Gruppe mit dem strategischen Fokus auf das globale Sportmotorradsegment und den automotiven high-tech Komponentenbereich. Mit ihren weltweit bekannten Marken KTM, Husqvarna Motorcycles, WP und Pankl zählt sie in ihren Segmenten jeweils zu den Technologie- und Marktführern.

>> Besuchen Sie 2 weitere Partner auf runplugged.com/partner





Runplugged App

runplugged.com/app


Weitere Aktivitäten

Facebook https://www.facebook.com/runplugged.social.laufapp
Runplugged Business Athlete Award: http://runplugged.com/baa



Blog

>>